CN101889666A - 一种多肽蜂胶及其生产工艺 - Google Patents
一种多肽蜂胶及其生产工艺 Download PDFInfo
- Publication number
- CN101889666A CN101889666A CN2010102148325A CN201010214832A CN101889666A CN 101889666 A CN101889666 A CN 101889666A CN 2010102148325 A CN2010102148325 A CN 2010102148325A CN 201010214832 A CN201010214832 A CN 201010214832A CN 101889666 A CN101889666 A CN 101889666A
- Authority
- CN
- China
- Prior art keywords
- propolis
- pure
- polypeptide
- cheese
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000241413 Propolis Species 0.000 title claims abstract description 89
- 229940069949 propolis Drugs 0.000 title claims abstract description 89
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 71
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 66
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 63
- 238000004519 manufacturing process Methods 0.000 title abstract description 11
- 239000005018 casein Substances 0.000 claims abstract description 38
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000021240 caseins Nutrition 0.000 claims abstract description 38
- 235000013351 cheese Nutrition 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 230000001877 deodorizing effect Effects 0.000 claims abstract description 8
- 238000005238 degreasing Methods 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000001694 spray drying Methods 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 28
- 238000013467 fragmentation Methods 0.000 claims description 24
- 238000006062 fragmentation reaction Methods 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 12
- 238000005516 engineering process Methods 0.000 claims description 11
- 239000003513 alkali Substances 0.000 claims description 10
- 235000005911 diet Nutrition 0.000 claims description 10
- 230000000378 dietary effect Effects 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 108090000526 Papain Proteins 0.000 claims description 8
- 239000004365 Protease Substances 0.000 claims description 8
- 229940055729 papain Drugs 0.000 claims description 8
- 235000019834 papain Nutrition 0.000 claims description 8
- 238000012856 packing Methods 0.000 claims description 6
- 210000000481 breast Anatomy 0.000 claims description 5
- 238000004332 deodorization Methods 0.000 claims description 5
- 238000002386 leaching Methods 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000007598 dipping method Methods 0.000 claims description 4
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 102000004142 Trypsin Human genes 0.000 claims description 3
- 108090000631 Trypsin Proteins 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 238000000247 postprecipitation Methods 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 229960001322 trypsin Drugs 0.000 claims description 3
- 239000012588 trypsin Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 230000036039 immunity Effects 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 238000001816 cooling Methods 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 238000001704 evaporation Methods 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 3
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 230000000249 desinfective effect Effects 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 1
- 230000001112 coagulating effect Effects 0.000 abstract 1
- 238000000151 deposition Methods 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 230000003345 hyperglycaemic effect Effects 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 230000009182 swimming Effects 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010066371 Tendon pain Diseases 0.000 description 1
- 230000004103 aerobic respiration Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
项目 | 要求 |
形态 | 固体 |
色泽 | 深棕黑色 |
滋味 | 具有蜂胶及酪蛋白活性多肽特有的味道 |
项目 | 限量 |
铅mg/kg ≤ | 2.0 |
汞mg/kg ≤ | 0.3 |
砷mg/kg ≤ | 1.0 |
项目 | 限量 |
菌落总数cfu/g ≤ | 30000 |
大肠菌数MPN/100kg ≤ | 90 |
霉菌cfu/g ≤ | 25 |
酵母cfu/g ≤ | 25 |
沙门氏菌 | 不得检出 |
志贺氏菌 | 不得检出 |
金黄色葡萄球菌 | 不得检出 |
溶血性链球菌 | 不得检出 |
组别 | 多肽蜂胶剂量(ml/kg) | 小鼠数量(只) | SOD(μg/mg) |
对照组 | 0 | 10 | 486.5±199.1 |
1 | 0.85 | 10 | 518.4±212.9 |
2 | 1.7 | 10 | 1378.5±344.2 |
3 | 5 | 10 | 1826.5±465.3 |
组别 | 多肽蜂胶剂量(ml/kg) | 小鼠数量(只) | SOD(μg/mg) |
对照组 | 0 | 10 | 208.2±115.7 |
1 | 0.85 | 10 | 216.9±115 |
2 | 1.7 | 10 | 424.6±136 |
3 | 5 | 10 | 565.6±190.6 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010214832A CN101889666B (zh) | 2010-06-30 | 2010-06-30 | 一种多肽蜂胶及其生产工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010214832A CN101889666B (zh) | 2010-06-30 | 2010-06-30 | 一种多肽蜂胶及其生产工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101889666A true CN101889666A (zh) | 2010-11-24 |
CN101889666B CN101889666B (zh) | 2012-10-03 |
Family
ID=43099154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010214832A Active CN101889666B (zh) | 2010-06-30 | 2010-06-30 | 一种多肽蜂胶及其生产工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101889666B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198084A (zh) * | 2018-09-14 | 2019-01-15 | 杭州和蜂园保健品有限公司 | 一种蜂胶袋泡茶的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162613A (zh) * | 1996-04-16 | 1997-10-22 | 边成均 | 蜂原胶提纯新工艺 |
CN1384204A (zh) * | 2001-04-27 | 2002-12-11 | 陆晓民 | 用粗奶酪生产酪蛋白活性多肽的工艺 |
CN1593191A (zh) * | 2004-07-14 | 2005-03-16 | 北京东方兴企食品工业技术有限公司 | 一种花粉、蜂王浆食品及其制备方法 |
-
2010
- 2010-06-30 CN CN201010214832A patent/CN101889666B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162613A (zh) * | 1996-04-16 | 1997-10-22 | 边成均 | 蜂原胶提纯新工艺 |
CN1384204A (zh) * | 2001-04-27 | 2002-12-11 | 陆晓民 | 用粗奶酪生产酪蛋白活性多肽的工艺 |
CN1593191A (zh) * | 2004-07-14 | 2005-03-16 | 北京东方兴企食品工业技术有限公司 | 一种花粉、蜂王浆食品及其制备方法 |
Non-Patent Citations (1)
Title |
---|
《httpwww.yft888.comxinwen_read-xwid-20100521123401078.html》 20100521 无 什么是多肽蜂胶? 1-2 , * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198084A (zh) * | 2018-09-14 | 2019-01-15 | 杭州和蜂园保健品有限公司 | 一种蜂胶袋泡茶的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101889666B (zh) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20100080972A (ko) | 나무수액 발효물과 그 이용방법. | |
CN101692908B (zh) | 一种具有补血、养颜、美容功能的双胶花粉食品及其制备方法 | |
CN110496214A (zh) | 一种改善男性性功能的牡蛎肽组合物及其制备方法 | |
TW201536341A (zh) | 紅藜萃取物用於製備促進膠原蛋白生成及抗皮膚老化之組合物之用途 | |
KR101670649B1 (ko) | 한약재 발효 추출물을 함유한 혼합 조성물 및 이의 제조방법 | |
CN102349608A (zh) | 一种清咽润喉的保健品组合物及其制备方法 | |
CN103734581B (zh) | 适用于术后人群康复的牦牛乳蛋白多肽营养粉及其制备方法 | |
CN1899513A (zh) | 强化微量元素的蛇龟酒及生产方法 | |
CN103431292A (zh) | 一种含有泥螺多肽和植物浸提粉的保健面条 | |
CN105996056A (zh) | 抗衰老胶原蛋白肽粉 | |
KR101272093B1 (ko) | 린테우스 상황버섯이 함유된 식용 달팽이 사료 및 그 사료를 이용한 식용 달팽이 사육방법 | |
CN101889666B (zh) | 一种多肽蜂胶及其生产工艺 | |
CN101889667B (zh) | 一种多肽花粉及其生产工艺 | |
CN115153033A (zh) | 一种调理机体营养不均衡的复合小分子肽配方 | |
CN1080131A (zh) | 一种美容保健营养食品和制备方法 | |
CN1535620A (zh) | 一种全蚕粉保健食品制备方法 | |
KR100289990B1 (ko) | 성장호르몬 분비 촉진용 생약재 조성물 및 이를 이용하여 제조한 성장호르몬 분비 촉진제 | |
CN102366103B (zh) | 一种适用于中老年男性机能维持的食品 | |
KR20050080501A (ko) | 고혈압, 비만, 당뇨병환자를 위한 건강보조식품의 제조방법 | |
CN105249221A (zh) | 一种南瓜香芋宝食品及其制备方法 | |
CN107006717A (zh) | 含有桑叶和蚕的鸡饲料 | |
KR20210001780A (ko) | 나노콜라겐펩타이드 킬레이트 칼슘 및 그의 제조방법 | |
CN109381366A (zh) | 可食用面膜及其制备方法 | |
CN109170804A (zh) | 一种适用于高血压患者的微藻多糖低钠盐及其制备方法 | |
CN114712481B (zh) | 一种复合植物源多肽及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WEIHAI KANGHAO BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LI GUOXI Effective date: 20131212 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710043 XI AN, SHAANXI PROVINCE TO: 264414 WEIHAI, SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131212 Address after: 264414 No. 3, righteousness Road, industrial new district, Shandong, Weihai, China Patentee after: Weihai good Biotechnology Co., Ltd. Address before: 710043 No. 52, five West Road, Xincheng District, Shaanxi, Xi'an Patentee before: Li Guoxi |